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Summary The comet assay was used to estimate radiobiological hypoxic fraction across a full range of tumour oxygenations in C3H
mammary tumours implanted into the feet of female CDF1 mice. Tumours were either clamped before irradiation or mice were allowed to
breath air, 100% oxygen, carbogen or carbon monoxide for 5-35 min before and during exposure to 15 Gy. For the alkaline comet assay,
tumours were excised after irradiation and individual tumour cells were analysed for DNA single-strand breaks. Hypoxic cells were defined as
those cells with approximately three times fewer single-strand breaks than aerobic cells. Radiobiological hypoxic fraction was calculated by
fitting DNA damage histograms to two normal distributions, representing the response of the aerobic and hypoxic populations. The percentage
of hypoxic cells estimated using the comet assay was then compared with hypoxic fraction measured using a clamped tumour control assay.
Carbogen and oxygen breathing reduced the normal hypoxic fraction from 14% to 2-3% in this tumour, whereas 75-660 p.p.m. carbon
monoxide progressively increased the hypoxic fraction from 18% to 82%. The slope of the line comparing the two methods was 1.23 with 95%
confidence limits of 1.12-1.33 (r2 = 0.994). In the SCCVII squamous cell carcinoma growing subcutaneously in C3H mice, a similarcorrelation
was observed between hypoxic fraction measured using the comet assay and hypoxic fraction measured in the same tumour cells using the
paired survival curve assay (slope = 1.20 with 95% confidence limits of 1.03-1.37). These results confirm the ability of the comet assay to
provide an accurate estimate of radiobiological hypoxic fraction over a wide range of tumour oxygenations and between two tumourtypes.
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For over 50 years, hypoxia in solid tumours has been considered to
be an important factor capable of limiting the success of conven-
tional radiotherapy (Gray et al, 1953; Bush et al, 1978). As only a
proportion of tumours of any one type is now believed likely to
contain hypoxic cells at the start of treatment, it is not surprising
that clinical trials of hypoxic-cell sensitizers and blood flow
modulators have generally shown little benefit when patient
numbers entered into trials have been relatively small (Gonzalez,
1991; Dorie and Brown, 1995). When 50 small trials (average
patient number = 97) were combined for meta-analysis, however,
hypoxic-cell radiosensitizers have demonstrated a benefit in
terms of local tumour control (Overgaard, 1994). Ideally, tumours
containing hypoxic cells should be identified before treatment in
order to direct the appropriate treatmentsjust to those patients who
are likely to benefit. To approach this question, a variety ofinnov-
ative methods have been developed in an effort to measure tumour
oxygenation or the presence of hypoxic cells in solid tumours
(Stone et al, 1993). Oxygen polarography has been used to
measure tumour oxygenation since the late 50s (Cater et al, 1959;
Kolstad, 1968; Gatenby et al, 1988), and advances in this tech-
nology have made clinical application ofthis method more reliable
and convenient (Vaupel et al, 1991; Nordsmark et al, 1994). Often
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considered to be the 'gold standard' for measurement of human
tumouroxygenation, this technique has undergone the most exten-
sive clinical testing, resulting in demonstration ofimportant corre-
lations between tumour oxygenation and outcome following
treatment (Hockel et al, 1993; Nordsmark et al, 1996). Within a
single murine tumour type, oxygen electrode measurements corre-
late with hypoxic fraction measured using conventional assays
(Horsman et al, 1993; Nordsmark et al, 1995). However, a limita-
tion identified by several groups is an inability to consistently
correlate hypoxic fraction with a specific tumour oxygenation
parameter between different tumour types (e.g. median oxygen
tension, per cent of readings less than 5 mmHg) (Horsman et al,
1994; Kavanagh et al, 1996). Apparently, the oxygen tension that
correlates with radiobiological hypoxia in one type oftumour may
differ from the oxygen tension that correlates with hypoxia in
another tumour type. This complicates interpretation of oxygen
tension measurements made in human tumours, although it should
not impact on the ranking of tumours for results obtained by an
individual laboratory for a defined histological type.
The comet assay was recently developed as a method for esti-
mating the radiobiological hypoxic fraction (Olive and Durand,
1992; Olive et al, 1993). Radiobiologically hypoxic cells sustain
about three times less DNA single-strand breaks than well-
oxygenated cells (Chapman et al, 1974; Zhang et al, 1995),
forming the basis for detection of individual hypoxic cells from
solid tumours. Previous results, using the comet assay in SCCVII
murine tumours, indicated good agreement between the hypoxic
fraction measured using the comet assay and hypoxic fraction
measured using the conventional paired survival curve assay
(Olive and Durand, 1992; Olive, 1994).
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To examine the ability of the comet assay to measure the
hypoxic.fraction over a wider range of tumour oxygenations,
tumour oxygen tension was increased by allowing mice to breathe
oxygen or carbogen, or decreased by breathing air containing
various amounts ofcarbon monoxide (Grau et al, 1994). Using this
approach, Horsman et al (1995) showed an excellent relationship
between tumour pO2 (both median p02 and per cent of readings
< 5 mmHg) and hypoxic fraction measured using a clamped
tumour control end point in a C3H mammary tumour model. All
experiments were performed in Aarhus, to allow comparison of
results obtained using the comet assay with clamped tumour
control data obtained using the C3H mammary tumour in Aarhus.
METHODS
Tumour models and irradiations
The majority of experiments were performed on 10 to 14-week-
old male CDF1 mice bearing a C3H mouse mammary carcinoma
whose derivation and maintenance have been described previously
(Overgaard, 1980). Tumours were implanted in the dorsum of the
right rear foot and treated when they had reached about 200 mm3
in size. The SCCVII squamous cell carcinoma was grown in the
dorsum of the foot (Aarhus) or implanted subcutaneously in the
back (Vancouver). SCCVII tumours implanted in the back were
used for experiments when they reached a size of 350-500 mg
(Olive, 1994). Mice were restrained in lucite jigs and allowed to
breathe 100% oxygen or carbogen (95% oxygen, 5% carbon
dioxide) for 5 min before and during irradiation, or various
percentages ofcarbon monoxide in air for about 35 min before and
during irradiation. The gas flow rate was 2.5 1 min-'. Foot tumours
were made totally hypoxic by clamping the tumour-bearing leg
with a rubber band 5 min before and during the irradiation,
whereas for back tumours, total hypoxia was achieved using a D-
shaped clamp applied for 5 min before and during irradiation. All
mice were unanaesthetized and those with foot tumours were
exposed to 15 Gy 250 kV X-rays at a dose rate of2.3 Gy min-', or
with back tumours at a dose rate of3.3 Gy min-'.
Measurement of radiobiological hypoxic fraction
To determine hypoxic fraction, C3H mammary tumours were
observed at weekly intervals after treatment and the percentage of
animals at each radiation dose showing local tumour control 90
days after irradiation was recorded. Hypoxic fractions were deter-
mined from direct analysis of the radiation dose-response data,
obtained from clamped or unclamped tumours as described previ-
ously (Bentzen and Grau, 1991). Clamped tumours for both
tumour control and paired survival curve assays were assumed to
contain 100% hypoxic cells. The average number of male mice
used to determine each dose-response curve was 235.
For the SCCVII tumour grown in C3H mice, a paired survival
curve method was used. Mice were exposed to 12 or 15 Gy while
breathing air, carbogen or following asphyxiation. Tumours were
immediately excised and divided into two parts. One part was
dissociated into single cells using an enzyme cocktail and plated
for colony formation (Olive and Durand, 1992). Colonies formed
from the surviving cells were counted 12 days later. To determine
the hypoxic fraction based on a paired surviving fraction, the
clonogenic fraction of cells from the air or carbogen-breathing
mouse was divided by the clonogenic fraction of cells from
tumours clamped during irradiation. The remaining part of the
tumour was used to measure hypoxic fraction using the comet
assay as described below.
Measurement of hypoxic fraction using the comet
assay
Six or more tumours were analysed for each gassing condition.
Tumours were excised within 30 s of the end of radiation expo-
sure, and were rapidly cooled by submersing in ice-cold phos-
phate-buffered saline (PBS). They were then chopped with crossed
scalpels in ice-cold PBS and filtered through 30-gm nylon mesh.
Cells were centrifuged and pellets were resuspended in PBS for
dilution to 2 x 104 cells ml-'. More 'background' DNA damage
was routinely observed in untreated tumour cells prepared by this
method compared with samples prepared using a conventional
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Figure 1 Radiation-induced DNA strand breaks in C3H tumours measured using the comet assay. A-G are representative histograms showing distributions of
tail moment from individual C3H mammary tumours exposed to 15 Gy while mice breathed different gas mixtures. The percentage of hypoxic cells shown in
each is determined using an iterative curve fitting program, assuming two normal distributions for the aerobic and hypoxic cells. H shows a typical response of
an unirradiated tumour
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Figure 2 Comparison between hypoxic fraction measured using the comet
assay and hypoxic fraction measured using a clamped tumour control end
point for C3H mammary tumours. Results for the comet assay are the means
and standard deviations for six to eight tumours. The hypoxic fraction (± 95%
confidence intervals) for the clamped tumour control data was determined
from full radiation dose-response curves. The average number of male mice
used to determine each dose response curve was 235. Lines are the linear
best fit and 95% confidence limits for all of the data
enzyme disaggregation procedure in which the tail moment was
closer to 2.0. However, this mechanical disaggregation procedure
was essential to avoid DNA repair that would occur during
enzyme disaggregation at 37°C.
Cell suspensions (0.5 ml) were placed in 5-ml disposable tubes
and 1.5 ml of 1% low gelling temperature agarose (Owl Scientific
low-gelling agarose prepared in distilled water and held at 40°C)
was added to the tube. Then, 1.5 ml was quickly pipetted onto a
half-frosted microscope slide and allowed to gel for about 1 min
on a cool surface. Slides were carefully submersed in an alkaline
lysis solution containing 1.2 M sodium chloride, 0.03 M sodium
hydroxide and 0.1% sarkosyl for 1 h, followed by a 1 h wash in
0.03 M sodium hydroxide, 2 mm EDTA before electrophoresis
in a fresh solution of 0.03 M sodium hydroxide, 2 mM EDTA
at 0.6 volts cm-' for 25 min. Slides were rinsed and stained for
10 min in 2.5 ,ug ml-' propidium iodide. After rinsing, slides were
dried in a 37°C or 50°C oven, and then placed in a light-tight
box for transport to Vancouver.
Before analysis, 1 ml ofagarose (1%) was pipetted onto the dry
slide to reduce background fluorescence for image analysis.
Individual cells or 'comets' were viewed using a Zeiss epifluores-
cence microscope attached to an intensified solid state charge-
coupled device camera and image analysis system (Olive et al,
1990). Under these conditions ofelectrophoresis, as the numberof
DNA strand breaks increased, the amount ofDNA able to migrate
away from the comet head increased proportionally to dose. The
'tail moment', defined as the product ofthe percentage ofDNA in
the comet tail multiplied by the distance between the means ofthe
head and tail distributions, and 'DNA content', defined as the total
fluorescence associated with an image, were measured. Tail
moment histograms were obtained from 400 or more comets from
the same treated population. Hypoxic fraction was determined by
90
80
-0
0-
cc_
C
z
0
70
60
50
A
50 0
B
100
0 50 100
Hypoxic fraction (tumour control)
Figure 3 Comparison between mean hypoxic fraction measured using a
tumour control assay and two comet descriptors: (A) tail moment and (B) per
cent DNA in comet tail. Means and standard deviations for six to eight
tumours, with 400 comets analysed for each tumour are shown. Lines are
the linear best-fit through the data and 95% confidence limits
iterative fitting of histograms of tail moment with two normal
distributions, representing the aerobic and hypoxic populations
(Olive and Durand, 1992; Olive et al, 1993). Slides were randomly
coded in Aarhus before analysis in Vancouver.
RESULTS
Representative tail moment histograms for tumours exposed to
15 Gy are shown in Figure 1A-G. Note the presence oftwo popu-
lations of cells, the less damaged population representing the
hypoxic cells of the tumour, and the more damaged population
representing the aerobic cells. The curve-fitting program uses a
free-fit iterative fitting technique to obtain the best-fit (least sum-
of-squares) to the histograms, assuming two normal distributions
displaced by a factor varying between 1.9 and 3.0. As expected,
the proportion ofhypoxic cells decreased as oxygen concentration
in the inspired gas increased or as carbon monoxide concentration
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Figure 4 Comparison between hypoxic fraction measured using the comet
assay and hypoxic fraction measured using a paired survival curve assay for
the SCCVII carcinoma. Means and standard deviations for the SCCVII
tumour growing subcutaneously in the back and irradiated in Vancouver (0).
Results for the comet assay performed on SCCVII tumours implanted in the
foot for air-breathing mice irradiated in Aarhus (V) Lines are the linear best
fit and 95% confidence limits for all of the data
decreased. The average displacement between the peaks was
2.1 ± 0.34 (mean ± standard deviation, n = 40).
Combined results for six to eight tumours per group are shown
in Figure 2 and are compared with the hypoxic fraction measured
using a clamped tumour control end point. The slope (± 95%
confidence limit) of the line is close to unity (1.2 ± 0.1) and has a
correlation coefficient of0.99.
The correlation between tumour control and either mean tail
moment or mean percentage of DNA in the comet tail is also
shown (Figure 3). This comparison of average response is not
subject to errors in fitting histograms and is similar to tumour
hypoxia measurements in which the fraction of hypoxic cells is
not specifically detected (i.e. median pO2, average binding of a
hypoxia marker).
SCCVII tumours grown subcutaneously in the back of
C3H/HeN mice were also examined forhypoxic fraction using the
comet assay and compared with results obtained using an in vitro
paired survival curve procedure for calculating hypoxic fraction
(Figure 4). In addition to experiments performed in Vancouver
(closed symbols in Figure 4), one set of six mice with SCCVII
tumours growing in the foot was prepared in Aarhus for comet
analysis. As expected, hypoxic fraction measured using the comet
assay for the smaller tumours grown in the foot in Aarhus
was significantly lower (P-value <0.05) than hypoxic fraction
measured for the larger subcutaneous SCCVII tumours in
Vancouver (0.082 vs 0.18). The value of hypoxic fraction for the
foot tumours determined using the comet assay was therefore
compared with the previously published value for this tumour
growing in the foot (0.002 ± 0.0015) using the paired survival
curve method (Grau et al, 1994). The slope of this line was found
to be 1.20 with 95% confidence limits of 1.03-1.37.
DISCUSSION
A good correlation was observed between hypoxic fraction for
C3H mammary tumours measured using the comet assay and
hypoxic fraction measured using the clamped tumour control end
point. As in the oxygen electrode method, the comet assay is able
to predict hypoxic fraction in this tumour across the full range of
tumouroxygenations. Although the comet assay did underestimate
hypoxic fraction, especially in tumours clamped before irradiation,
this could be explained by the presence of a small fraction of
damaged cells produced during the process oftumourexcision and
mincing used to prepare a single cell suspension. Experiments
with carbon monoxide may be subject to greater interanimal varia-
tion, and a smaller variation might have been seen for tumour
control experiments performed at the same time as comet experi-
ments. Although itis notpossible toperform both comet assay and
tumour control experiments on the same mouse, it is possible to
perform both comet and in vitro clonogenic assays using cells
from the same tumour. This couldbe animportant advantage in the
situation in which individual tumour response is variable.
Curve fitting of tail moment histograms for the detection of
hypoxic cells becomes less accurate as the proportion ofhypoxic
or oxic cells is reduced below about 5%. The comparison between
tumour control and the raw data obtained using the comet assay
(mean tail moment and % DNA in the tail), avoids any bias that
might occur in fitting histograms and confirms the ability of the
comet assay to detect changes in DNA single-strand breaks that
relate to tumour oxygenation (Figure 3). However, in general, raw
data are not as useful for measuring tumour hypoxic fraction as
results are highly dependent on single-strand break rejoining time
during and after irradiation. In contrast, in ourexperience, hypoxic
fraction measured by fitting tail moment histograms (Figure 1) is
largely independent ofradiation dose overthe range of4-15 Gy, is
apparently not affected by repair time (Olive et al, 1994) and is
much less dependent on small variations in experimental condi-
tions for the comet assay.
The oxygen electrode method is able to provide an indication of
tumour hypoxia across a wide range of tumour oxygenations
within a single tumour type. However, there is an apparent
inability to correlate pO2 measurements with hypoxic fraction
across different tumour types (Horsman et al, 1994; Martin et al,
1994; Kavanagh et al, 1996). Gerwick et al (1995) and Rofstad et
al (1988) have also found that tumour adenylate energy charge,
NTP/Pi and PCr/Pi ratios do not correlate with radiobiological
hypoxia across tumour types, although they are effective indica-
tors within a single tumour type. Nitroimidazole markers, unless
analysed at the level of the individual cell, will also produce a
signal dependent on nitroreductase activity of the particular
tumour, so that the same amount of nitroimidazole binding in
different tumour or tissue types cannot be assumed to indicate the
same degree ofhypoxia (Franko et al, 1987; Cline et al, 1994).
For oxygen electrode measurements, the inability to measure
hypoxic fraction reliably across tumour types may result for
several reasons. The two most probable explanations are that the
fraction of clonogenic hypoxic cells varies for different tumour
types (Fenton et al, 1995; Horsman et al, 1995), and that variable
degrees ofnecrosis complicate interpretation ofhypoxia (Biade et
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al, 1995; Khalil et al, 1995). It is also possible that enzymatic or
biochemical factors (unrelated to oxygenation) influence oxygen
electrode current readings; recent results indicate that melanin
content of cells can influence pO2 measurements (Thomas and
Guichard, 1996). Differences in vascular density or sensitivity
of blood vessels to damage by electrodes may affect tumour
oxygenation unrelated to tumour pO2 (e.g. if bleeding during
measuremnent affects pO2 readings). As the hypoxic fraction of
solid tumours depends on the method used to detect hypoxia
(Moulder and Rockwell, 1984), the 'true' hypoxic fraction is
somewhat illusory. The tumour control assay used for these C3H
mammary tumours, perhaps, comes closest to measuring the rele-
vant hypoxic fraction.
For several reasons, intertumour differences are less likely to
influence detection of hypoxic cells using the alkaline comet
assay:
1. The comet assay measures the response ofindividual cells, so
that necrotic material or heavily damaged cells do not influ-
ence the estimation ofhypoxic fraction.
2. Cells defined to be hypoxic by this method are radiobiologi-
cally hypoxic as the relation between oxygen concentration
and DNA damage is the same as the relation between oxygen
concentration and cell killing (Chapman et al, 1974; Zhang et
al, 1995).
3. The comet assay measures the fraction ofradiobiologically
hypoxic cells present in tumours at the time ofirradiation so
that the influence ofextraneous conditions should affect the
comet assay to the same extent as the tumour control end
point.
4. Biochemical factors that might influence estimation ofhypoxic
fraction using electrodes or hypoxia markers, do not appear to
influence the measurement ofhypoxic fraction using the comet
assay (Zhang and Wheeler, 1994).
5. Whereas the comet assay is invasive, biopsy occurs after the
signal (strand breakage) is produced.
Hu et al (1995) have compared the comet assay with Eppendorf
oxygen electrode measurements, [3H]misonidazole binding and
hypoxic fraction determined using paired survival curve analysis.
Using four murine tumours, these authors also concluded that the
comet method could detect intertumour differences in hypoxic
fraction, although values of hypoxic fraction were two to four
times lower than those obtained using the paired survival curve
method. Although agreement with [3H]misonidazole binding was
reasonable, correlation with oxygen electrode measurements was
poor. Unfortunately, the range of tumour oxygenations in experi-
ments by these authors was distributed rather narrowly, making
correlations between these methods more difficult. However, our
results with two tumour types over a wide range of tumour
oxygenation lend further support to the conclusion that inter-
tumour differences can be reliably detected using the comet assay.
The ability to obtain information from a single fine-needle aspirate
is an important practical advantage, although there is always the
concern that the sample may not be representative ofthe tumour as
a whole. Recent analysis of three separate fine-needle aspirates
from ten human tumours provides some reassurance on this point
(Olive et al, 1996). The comet assay, as in other methods, cannot
differentiate between clonogenic and non-clonogenic hypoxic
cells. Some differences in hypoxic fraction measured using the
comet assay and hypoxic fraction measured using a clonogenic
end point would therefore seem inevitable. However, the excellent
agreement between the results using the SCCVII tumour and the
C3H mammary tumour is encouraging. More serious practical
concerns are the requirement of3.5-4 Gy to be given immediately
before fine-needle aspiration biopsy, and the potential influence of
circulating white blood cells in the fine-needle aspirate. It is hoped
that these are not insurmountable limitations for the routine
application of this method in the clinic. Considering the different
advantages and disadvantages of the various methods, the comet
assay should complement other techniques currently used, or
being considered for use, to estimate hypoxic fraction in human
solid tumours.
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